These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9873216)

  • 1. Medical prevention of renal stone disease.
    Pak CY
    Nephron; 1999; 81 Suppl 1():60-5. PubMed ID: 9873216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis.
    Pearle MS; Roehrborn CG; Pak CY
    J Endourol; 1999 Nov; 13(9):679-85. PubMed ID: 10608521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Etiopathogenesis and clinical aspects of nephrolithiasis--at present].
    Ferrari L; Meschi M; Musini S; Frattini A; Savazzi GM
    Recenti Prog Med; 2003 Mar; 94(3):136-41. PubMed ID: 12677782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Randomized trials in the prevention of recurrent calcium oxalate stones].
    Presne C; Monge M; Bataille P; el Esper N; Choukroun G; Fournier A
    Nephrologie; 2003; 24(6):303-7. PubMed ID: 14584297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
    Caudarella R; Vescini F
    Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of nephrolithiasis.
    Pearle MS
    Curr Opin Nephrol Hypertens; 2001 Mar; 10(2):203-9. PubMed ID: 11224695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of "specific" potassium citrate therapy versus conservative management in nephrolithiasis of mild to moderate severity.
    Preminger GM; Harvey JA; Pak CY
    J Urol; 1985 Oct; 134(4):658-61. PubMed ID: 3897582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical management of stone disease.
    Delvecchio FC; Preminger GM
    Curr Opin Urol; 2003 May; 13(3):229-33. PubMed ID: 12692447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diet and renal stone formation.
    Trinchieri A
    Minerva Med; 2013 Feb; 104(1):41-54. PubMed ID: 23392537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do thiazides prevent recurrent idiopathic renal calcium oxalate stones?
    Wolf H; Brocks P; Dahl C
    Proc Eur Dial Transplant Assoc; 1983; 20():477-80. PubMed ID: 6361755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
    Pak CY; Heller HJ; Pearle MS; Odvina CV; Poindexter JR; Peterson RD
    J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of recurrent calcium stones: diet versus drugs.
    Jaeger P
    Miner Electrolyte Metab; 1994; 20(6):410-3. PubMed ID: 7783704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal stone clinic survey: calcium stone formers' self-declared understanding of and adherence to physician's recommendations.
    Hess B
    Urolithiasis; 2017 Aug; 45(4):363-370. PubMed ID: 27573100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder.
    Coe FL
    Ann Intern Med; 1977 Oct; 87(4):404-10. PubMed ID: 907239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is selective therapy of recurrent nephrolithiasis possible?
    Pak CY; Peters P; Hurt G; Kadesky M; Fine M; Reisman D; Splann F; Caramela C; Freeman A; Britton F; Sakhaee K; Breslau NA
    Am J Med; 1981 Oct; 71(4):615-22. PubMed ID: 7282750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Future perspective on the prevention of nephrolithiasis].
    Kohjimoto Y; Shinka T; Morimoto S; Nishihata M
    Hinyokika Kiyo; 2004 Aug; 50(8):591-6. PubMed ID: 15471083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.